Barinthus Biotherapeutics (BRNS)
NASDAQ: BRNS
· Real-Time Price · USD
1.13
0.00 (0.00%)
At close: Sep 12, 2025, 3:44 PM
Barinthus Biotherapeutics Revenue
Barinthus Biotherapeutics reported an annual revenue of $14.97M, reflecting a 1766.46% growth. For the quarter ending June 30, 2025, Barinthus Biotherapeutics generated $0 in revenue.
Revenue (ttm)
14.97M
Revenue Growth
1766.46%
Price / Sales Ratio
3.18
Revenue / Employee
142.56K
Employees
105
Market Cap
45.59M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 14.97M | +1766.46% |
| Dec 31, 2023 | 802K | -98.21% |
| Dec 31, 2022 | 44.7M | +16580.22% |
| Dec 31, 2021 | 268K | -94.44% |
| Dec 31, 2020 | 4.82M | -29.86% |
| Dec 31, 2019 | 6.87M | n/a |